An Alzheimer's vaccine developed by a privately held Slovakian biotech firm showed early signs of efficacy in a mid-stage trial, a rare step forward in the fight against the brain-wasting disease, the company said on Monday.
from Reuters: Health News https://ift.tt/2ZNnWxA
via
IFTTT
0 comments:
Post a Comment